-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Bluejay Diagnostics (NASDAQ:BJDX) shares rose 182.5% to $6.13 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.2 million.
  • Picard Medical (AMEX:PMI) shares moved upwards by 85.39% to $0.31. The market value of their outstanding shares is at $15.7 million.
  • Quantum Cyber (NASDAQ:QUCY) shares rose 30.49% to $2.91. The market value of their outstanding shares is at $50.7 million.
  • Jin Medical International (NASDAQ:ZJYL) stock increased by 22.95% to $3.0. The company's market cap stands at $19.0 million.
  • Advanced Biomed (NASDAQ:ADVB) stock increased by 20.81% to $5.31. The company's market cap stands at $7.1 million.
  • Conexeu Sciences (NASDAQ:CNXU) stock moved upwards by 17.2% to $16.55. The market value of their outstanding shares is at $295.3 million.

Losers

  • Fulcrum Therapeutics (NASDAQ:FULC) stock declined by 51.5% to $3.11 during Tuesday's pre-market session. The company's market cap stands at $427.7 million.
  • Abivax (NASDAQ:ABVX) shares decreased by 32.71% to $87.27. The market value of their outstanding shares is at $10.3 billion.
  • Aditxt (NASDAQ:ADTX) shares decreased by 17.7% to $0.09.
  • PRF Technologies (NASDAQ:PRFX) stock declined by 11.89% to $1.78. The market value of their outstanding shares is at $1.7 million.
  • Praxis Precision Medicine (NASDAQ:PRAX) shares declined by 10.19% to $301.01. The company's market cap stands at $9.3 billion.
  • 20/20 Biolabs (NASDAQ:AIDX) shares fell 8.69% to $0.94. The market value of their outstanding shares is at $10.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending